<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: A tenth of patients with involuntary <z:hpo ids='HP_0001824'>weight loss</z:hpo> (IWL) have <z:e sem="disease" ids="C0685938" disease_type="Neoplastic Process" abbrv="">gastrointestinal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Ferritin is the first parameter to be modified during the process leading to <z:e sem="disease" ids="C0240066" disease_type="Disease or Syndrome" abbrv="">iron deficiency</z:e> <z:hpo ids='HP_0001903'>anaemia</z:hpo>, therefore it should be the most sensitive </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study was to assess the ability of ferritin to rule out <z:e sem="disease" ids="C0685938" disease_type="Neoplastic Process" abbrv="">gastrointestinal cancer</z:e> in patients with involuntary <z:hpo ids='HP_0001824'>weight loss</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: <z:hpo ids='HP_0000001'>All</z:hpo> consecutive patients with IWL admitted in a secondary care university hospital were prospectively studied </plain></SENT>
<SENT sid="4" pm="."><plain>Ferritin, <z:chebi fb="34" ids="35143">haemoglobin</z:chebi> with erythrocyte indices and serum iron were recorded for <z:hpo ids='HP_0000001'>all</z:hpo> patients </plain></SENT>
<SENT sid="5" pm="."><plain>The reference standard was bidirectional endoscopy and/or 6 months follow-up </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: 290 patients were included, a quarter had <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, of which 22 (7.6%) had <z:e sem="disease" ids="C0685938" disease_type="Neoplastic Process" abbrv="">gastrointestinal cancer</z:e> (8 <z:hpo ids='HP_0012126'>gastric cancer</z:hpo>, 1 ileum <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, 13 colorectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>) </plain></SENT>
<SENT sid="7" pm="."><plain>Ferritin had the best area under the curve (AUC), both for <z:e sem="disease" ids="C0685938" disease_type="Neoplastic Process" abbrv="">gastrointestinal cancer</z:e> (0.746, CI: 0.691-0.794), and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (0.765, CI: 0.713-0.813), compared to the other parameters of <z:e sem="disease" ids="C0240066" disease_type="Disease or Syndrome" abbrv="">iron deficiency</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>In the diagnosis of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, ferritin with a cut-off value of 100 mcg/L had a sensitivity of 93% (CI: 69-100%), and negative likelihood ratio of 0.13, with a negative predictive value of 99% (96-100%), while for <z:e sem="disease" ids="C0685938" disease_type="Neoplastic Process" abbrv="">gastrointestinal cancer</z:e>, the sensitivity was lower (89%, CI: 67-95%), with a negative likelihood ratio of 0.24 </plain></SENT>
<SENT sid="9" pm="."><plain>There were three false negative patients, two with <z:hpo ids='HP_0012126'>gastric cancer</z:hpo>, and one with <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: In patients with involuntary <z:hpo ids='HP_0001824'>weight loss</z:hpo>, a ferritin above 100mcg/L could rule out <z:hpo ids='HP_0003003'>colon cancer</z:hpo>, but not gastric or <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> </plain></SENT>
</text></document>